GlyCare™ 2FL/DFL will be available as a mix of 2'FL and DFL
2'FL (2'fucosyllactose) is the most abundant fucosylated Human Milk Oligosaccharide (HMO) in human milk at ~2g/L1 and can positively impact the health of infants :
- A protective role; preventing infection of the gut
- Improve gut barrier and immune regulation
- Important for cognitive development
DFL (DiFucosyllactose or Lactodifucotetraose, LDFT) is a highly abundant fucosylated HMO in human milk. Some primary known benefits of DFL include reducing infection by inhibiting the adhesion of pathogenic bacteria and positively supporting gut health by selectively stimulating bifidobacteria.
GlyCare™ 2FL/DFL will be available as a mix of 2'FL and DFL in a ratio close to the composition naturally found in breast milk. GlyCare™ 2FL/DFL has been approved as a Novel Food in Europe and regulatory filings have been made in the US. Preparation is on way for other major markets.
GlyCare™ 2FL/DFL will be commercially available from 2020.
 Erney, R. M., et al., 2000. J Pediatr Gastroenterol Nutr: 30, 181-92.